Latest News

Don’t overreact, keep your options open and develop off-ramps so you’re prepared regardless of the changes to come with AI.

Catch up on the top radiology content of the past week.

In a recent interview at the RSNA conference, Roland Rott shared his perspective on the planned acquisition of Intelerad by GE HealthCare along with insights on key synergies and future directions.

In a recent interview at the RSNA conference, Manisha Bahl, M.D., discussed new research examining the use of slab reconstruction technology with digital breast tomosynthesis (DBT), and its potential in reducing interpretation time and imaging volume.

In a recent interview at the RSNA conference, Talissa Altes, M.D., and Konstanze Diefenbach, M.D., discussed the potential utility and recent research findings on the use of the MRI contrast agent gadoquatrane for pediatric patients.

For men with a 1 μg/m3 increase in ten-year exposure to fine particulate matter, a common air pollutant, there was a 47 increased likelihood of moving to a higher CAD-RADS stenosis category, according to new coronary CT angiography research presented at the Radiological Society of North America (RSNA) conference.

The Breast Suite software reportedly provides automated localization of regions of interest on mammograms as well as AI-enabled assessments of breast density and stratification of breast cancer risk for up to two years.

Absent flow to perforator vessels in the face occurred in over 40 percent of women who had cosmetic fillers, according to new vascular ultrasound research presented at the RSNA conference.

Preliminary research has shown that the Vanquish Water Vapor Ablation System eliminated MRI-visible intermediate-risk PCa in over 90 percent of patients.

In a recent interview at the RSNA conference, Constance Lehman, M.D., Ph.D., discussed new research, which compared image-based AI for mammography versus breast density assessment in evaluating breast cancer risk.

In lieu of compensation bumps and increased PTO, awareness of a points-based system for job performance may provide an alternate motivational spark.

The addition of ClearCEM to Mammomat B.brilliant devices reportedly enhances differentiation of suspicious areas in image reconstruction and facilitates improved accuracy with tomosynthesis-guided biopsies.

In a recent interview, Stamatia Destounis, M.D., discussed new research, which showed that over 20 percent of breast cancer was detected in women under 50 years of age and that 80 percent of these cases involved invasive breast cancer.